LakePharma is pleased to organize its annual Symposium to bring together individuals and organizations in the biotech community to discuss the latest developments in biologics.
The 2018 symposium will cover topics such as the latest advances in antibody development, as well as innovative technologies that are helping to bring about the next generation of protein therapeutics and products including cell therapies.
The conference is designed to benefit scientists currently working in the biopharmaceutical industry who want to improve their awareness of the latest advancements in protein engineering and antibody discovery, as well as non-scientists who seek a better understanding of the processes, challenges and opportunities in the industry.
Hua Tu, Ph.D. CEO, LakePharma, Inc.
Norman Garceau, Ph.D. VP, Technology, LakePharma, Inc.
Yuko Terasawa, Ph.D. SVP, Corporate Development, Nanomolar, Inc.
Steven Banerjee, Founder and CEO, Mekonos
Damien Bates, M.D., Ph.D., FRACS, MBA, Chief Medical Officer & Head of Research at SanBio
Prasun Mishra, Ph.D., Founder and CEO, Agility Pharmaceuticals
Janette Phi, COO, Xcell Biosciences
Deepak Srivastata, M.D., President, Gladstone Institutes
Hong Tan, Ph.D., CEO, Probe Life
Yuko Terasawa, Ph.D., SVP, Corporate Development, Nanomolar
Hua Tu, Ph.D., CEO, LakePharma
Jordon Wang, Ph.D., VP, Antibody Discovery, LakePharma
8:00 Breakfast and Registration
8:55 Welcome Remarks
Morning Session I
9:00 – 9:30 am: Jordon Wang, Ph.D., VP, Antibody Discovery, LakePharma
“LakePharma Antibody Center update”
9:35 – 10:10 am: Deepak Srivastata, M.D., President, Gladstone Institutes
“Cardiac Development: Basis for Disease and Regeneration”
10:15-10:40 Morning Break
Morning Session II: ADCs and Bispecifics
10:45 – 11:20 am: Damien Bates, M.D., Ph.D., FRACS, MBA, Chief Medical Officer & Head of Research, SanBio
“Clinical Development of MSCs for Chronic Neurological Deficits – the SanBio Experience”
11:20 – 11:55 am: Prasun Mishra, Ph.D., Founder and CEO, Agility Pharmaceuticals
“Cell therapy: New Frontiers and New Challenges”
12:00– 1:15 pm: Lunch and Breakout Mini Sessions
12:40 – 1:10 pm: Breakout Mini Sessions
Jaymee Davis, Cell Therapy Business Development Manager, Thermo Fisher
“Next Generation Cell & Gene Therapy Products: The Market, The Tools, The Future”
Yasmina Abdiche, Ph.D., Chief Scientific Officer, Carterra
"Accelerating Biotherapeutic Discovery with High Throughput Array SPR”
Paul Jurcys, SVP IP Management, Nanomolar
"List and License Technologies: Anticipate the Next Technological Breakthrough"
1:15 Brief Remarks
Afternoon Session I
1:20 – 1:50 pm: Hua Tu, Ph.D., CEO, LakePharma
“Update on LakePharma”
1:55 – 2:30 pm: Hong Tan, Ph.D., CEO, Probe Life
"BLI and Beyond"
2:30 – 3:00 Poster Session and Break
Afternoon Session II
3:05 – 3:40 pm: Steven Banerjee, Founder and CEO, Mekonos
“Point-of-care Gene Therapies using Silicon Chip Architecture”
3:45 – 4:20 pm: Janette Phi, COO, Xcell Biosciences
“Control Phenotypic and Genotypic Profiles in Conjunction with Rapid Expansion of Immune Cells, Stem Cells and Tumor Organoids by Mimicking the Human Microenvironment”
4:20 RAFFLE AND CLOSING REMARKS
4:30 – 5:30 Networking and Happy Hour
Online registration is now closed. Onsite registration will open at 8 am.
ONLINE REGISTRATION IS NOW CLOSED.
Limited space is available for onsite registration on Friday, first come, first served.
Please contact email@example.com for more information.